Cingulate Inc. Warrants

YTD

ALL

Why Robinhood?

You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!

About CINGW

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

CEO

Jennifer L. Callahan, CPA

CEOJennifer L. Callahan, CPA

Employees

—

Employees—

Headquarters

Kansas City, Kansas

HeadquartersKansas City, Kansas

Founded

2013

Founded2013

Employees

—

Employees—

CINGW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

15.03K

Average volume15.03K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.175

52 Week high$0.175

52 Week low

$0.0199

52 Week low$0.0199